Vice Provost and Dean of Research
Showing 201-250 of 599 Results
-
Paul S Humphries
Alliance Director, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAlliance Director, Stanford Innovative Medicines Accelerator (IMA)
-
Patrick Hynes
Senior Manager of Research Communities, Institute for Human-Centered Artificial Intelligence (HAI)
Current Role at StanfordSenior Manager of Research Communities at Stanford HAI
-
Amy Jacobson
Director of Microbiome Therapies, Microbiome Therapies Initiative (MITI)
Current Role at StanfordSenior Scientific Program Manager, Sarafan ChEM-H and Stanford Innovative Medicines Accelerator
-
Hongchen Jiang
Staff Scientist, SLAC National Accelerator Laboratory
Current Role at StanfordStaff Scientist
-
Ann R. Johnson
Associate Vice Provost, Research Compliance, Vice Provost and Dean of Research - Research Compliance
BioDr. Johnson is the Associate Vice Provost for Research Compliance at Stanford University, overseeing both human and animal research compliance programs. She specializes in research ethics and is an expert in human subjects research regulations and requirements. She is an active member of the research community having conducted research in the fields of public health and research ethics. She has taught undergraduate- and graduate-level courses and is an ardent supporter of research education. She participates in many national forums with the federal government, accrediting bodies, commercial IRBs, and academic research institutions to address problems and priorities for research oversight and quality. She helped establish a single IRB process for the University of Utah and the National Center for Advancing Translational Science-funded Trial Innovation Network. She also worked closely with the SMART IRB initiative to provide harmonized guidance on IRB reliance and the functions of human research protection programs. She also serves as a site visitor for the Association for the Accreditation of Human Research Protection Programs.
-
Theodore Kamins
Adjunct Professor, Electrical Engineering
Researcher, Hansen Experimental Physics Laboratory (HEPL)BioTed received his degrees from the University of California, Berkeley. He then joined the Research and Development Laboratory of Fairchild Semiconductor, where he worked with epitaxial and polycrystalline silicon before moving to Hewlett-Packard Laboratories, where he worked on numerous semiconductor material and device topics. Before moving to Stanford, he was a Principal Scientist at Hewlett-Packard in the Information and Quantum Systems Laboratory, where he conducted research on advanced nanostructured electronic and sensing materials and devices.
Ted is co-author with R. S. Muller of the textbook "Device Electronics for Integrated Circuits" and is author of the book "Polycrystalline Silicon for Integrated Circuits and Displays." He is a Fellow of the IEEE and a Fellow of the Electrochemical Society. He has taught at the University of California, Berkeley, and at Stanford University and has been an Associate Editor of the IEEE Transactions on Electron Devices. -
Madeleine Douglass Kieca
Industrial Contracts Offcr 1, Office of Technology Licensing (OTL)
BioMaddy is an Industrial Contracts Officer in the Office of Technology Licensing at Stanford after practicing as an attorney for over ten years external to the University. Maddy has experience negotiating and drafting contracts as well as interfacing directly with various individual and entity clients. She received her BA in English with an emphasis in Creative Writing from the University of Southern California and her JD from Santa Clara University School of Law. She is admitted to practice law in the State of California.
-
Hyunjin Kim
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioHyunjin is a Licensing Manager at Stanford Office of Technology Licensing. Hyunjin holds a PhD in Biochemistry from the University of Illinois at Chicago. With a strong foundation in life sciences, Hyunjin joined Aspire Capital as a biotech analyst intern where she gained valuable experience in analyzing and assessing biotech companies with clinical stage assets. After the internship, Hyunjin joined the Office of Technology Management at University of Illinois at Chicago where she managed various intellectual properties. At Stanford, Hyunjin is responsible for managing life science portfolios.
-
Kevin Kinast
Health & Safety Specialist, Environmental Health and Safety (EH&S)
Current Role at StanfordSupervise Waste Programs with the Environmental Protection Program
-
Pallavi Kompella
Lead Research Scientist, Animal Pharmacology, Innovative Medicines Accelerator (IMA)
BioPh.D. Pharmaceutical Sciences, The University of Texas at Austin, Texas
(American Foundation for Pharmaceutical Education Doctoral Fellow)
Fulbright Postdoctoral Scholar, Biomedical Research Institute of Malaga, Spain -
Rohini Kosoglu
Affiliate, Biodesign Health Tech Policy
BioRohini Kosoglu is a leading national expert on domestic policy and veteran of the White House, Congress, and presidential campaigns. She currently serves as a Policy Fellow at the Stanford Institute for Human-Centered Artificial Intelligence (HAI) and Director of Public Policy and Political Affairs at the Stanford Byers Center for Biodesign. She is also a Venture Partner at Fusion Fund, a venture firm that focuses on early-stage technology and health care investments. Kosoglu has been at the forefront of driving transformative change in social, technology, and economic policy over the last two decades. She also has the distinction of being the first South Asian American woman to hold the roles of both Domestic Policy Advisor to the Vice President and Chief of Staff in the United States Senate.
Kosoglu recently served as Deputy Assistant to the President and Domestic Policy Advisor to the Vice President. In this role, Kosoglu became the first Asian American woman to hold this position. She led and promoted initiatives on behalf of the President and Vice President to strengthen democracy, advance gender and racial equity, and create economic mobility for millions of American workers and families. Kosoglu also served as a key advisor during the creation and implementation of the American Rescue Plan, including the national response to the COVID-19 crisis, the CHIPS Act, the AI Bill of Rights, the bipartisan infrastructure law and the Cancer Moonshot. On behalf of the Vice President, she helped forge a number of public-private partnerships in the White House, ultimately driving billions of private sector dollars towards national priorities of the President and Vice President and leveraged the strengths of both the government and private-sector. Vice President Harris praised Kosoglu as “a brilliant and trusted leader” who “brought vision, strategic judgement, and a depth of experience as our Administration has addressed some of the most urgent challenges facing our nation.”
Earlier, Kosoglu made history as the first South Asian American woman to serve as Chief of Staff in the United States Senate under then-U.S. Senator Kamala Harris. She managed hearing preparations for some of the highest-profile Senate hearings over the last decade including investigations around data privacy, cybersecurity, and social media interference during the 2016 U.S. presidential election, as well as Supreme Court nomination hearings. Additionally, under her organizational leadership, the Joint Center for Political and Economic Studies named Harris’ office under Kosoglu's tenure as the most diverse in the U.S. Senate.
Kosoglu’s career in the United States Congress has also included over a decade of leadership positions crafting social, economic, and technology policy initiatives with senior Democratic Senators, including U.S. Senator Michael Bennet of Colorado and U.S. Senator Debbie Stabenow of Michigan. Notably, Kosoglu was a key negotiator during the passage of the historic Affordable Care Act. She also was a lead negotiator and drafter during the reform of the Food and Drug Administration which led to landmark designations for approval of innovative drugs and devices, known today as Breakthrough Therapies and Breakthrough Devices, respectively, as well as laws to strengthen patient-centered care in the 21st Century Cures Act.
Kosoglu was a former resident fellow at the Harvard Institute of Politics at the Kennedy School and received her bachelor’s degree with honors from the University of Michigan and a master’s degree from George Washington University. She serves on several nonprofit boards and advises across the public and private sectors.
